Cervical cancer was designated a global health priority by the World Health Organization in
2018. Though preventable, cervical cancer is expected to affect 700,000 women and claim …

Background: High-risk human papillomavirus (hrHPV)-based cervical cancer screening in
the Netherlands led to a substantial increase in number of colposcopy referrals and low …

Currently, clinical data for primary HPV screening alone are lacking in China. Here, we
evaluate cervical cancer screening with primary HPV genotyping, as well as possible future …

Aim Many cervical cancers occurs among women over 65 and prevalence of HPV
genotypes in this age cohort is sparingly studied. One aim of this study was to study the …

Introduction Selective utilization of human papillomavirus (HPV) genotyping in cervical
cancer screening can accelerate clinical management, leading to earlier identification and …

Abstract Objective Human papillomavirus (HPV) 16/18 genotyping is an effective method for
triage of high-risk (hr) HPV-positive women in primary hrHPV screening for cervical cancer …

In January 2020, a different cervical cancer screening program started in Germany. Women
above the age of 35 are recommended to have a combined HPV and cytology swab every …

Background: We sought to identify the absolute risk of specific HPV genotype for cervical
intraepithelial neoplasia grade 2/3 or worse (CIN2+/3+) and to develop a risk-based …

Since 2012, testing high‐risk (HR) HPV has been used as the primary screening test for
women≥ 35 years attending the organized cervical cancer screening program in the city of …

Background Human papillomavirus (HPV) is a necessary cause of cervical cancer, and a
tool more sensitive than cytology for the early screening of cervical precancers. The two …